MAR-DOXEPIN DIN 02559099
Status: Marketed
Holder: MARCAN PHARMACEUTICALS INC
Molecule: DOXEPIN (DOXEPIN HYDROCHLORIDE)
Available to quote
Health Canada record
| Active ingredient(s) | DOXEPIN (DOXEPIN HYDROCHLORIDE) 25 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06AA12 DOXEPIN |
| Original market date | 06-Aug-2025 |
| Current status date | 06-Aug-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Marcan Pharmaceuticals Inc. — licence 101909, currently licensed, last inspection rating C (2024-05-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DOXEPIN (DOXEPIN HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02049996 | APO-DOXEPIN | APOTEX INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 10 MG | Marketed |
| 02050048 | APO-DOXEPIN | APOTEX INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 100 MG | Marketed |
| 02050021 | APO-DOXEPIN | APOTEX INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 75 MG | Marketed |
| 02050013 | APO-DOXEPIN | APOTEX INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 50 MG | Marketed |
| 02050005 | APO-DOXEPIN | APOTEX INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 25 MG | Marketed |
| 02559250 | JAMP DOXEPIN | JAMP PHARMA CORPORATION | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 10 MG | Marketed |
| 02559285 | JAMP DOXEPIN | JAMP PHARMA CORPORATION | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 75 MG | Marketed |
| 02559293 | JAMP DOXEPIN | JAMP PHARMA CORPORATION | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 100 MG | Marketed |
| 02559277 | JAMP DOXEPIN | JAMP PHARMA CORPORATION | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 50 MG | Marketed |
| 02559269 | JAMP DOXEPIN | JAMP PHARMA CORPORATION | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 25 MG | Marketed |
| 02551349 | JAMP DOXEPIN TABLETS | JAMP PHARMA CORPORATION | Tablet | DOXEPIN (DOXEPIN HYDROCHLORIDE) 6 MG | Approved |
| 02551330 | JAMP DOXEPIN TABLETS | JAMP PHARMA CORPORATION | Tablet | DOXEPIN (DOXEPIN HYDROCHLORIDE) 3 MG | Approved |
| 02559102 | MAR-DOXEPIN | MARCAN PHARMACEUTICALS INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 50 MG | Marketed |
| 02559129 | MAR-DOXEPIN | MARCAN PHARMACEUTICALS INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 100 MG | Marketed |
| 02559110 | MAR-DOXEPIN | MARCAN PHARMACEUTICALS INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 75 MG | Marketed |
| 02559080 | MAR-DOXEPIN | MARCAN PHARMACEUTICALS INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 10 MG | Marketed |
| 02398257 | SILENOR | KNIGHT THERAPEUTICS INC. | Tablet | DOXEPIN (DOXEPIN HYDROCHLORIDE) 3 MG | Marketed |
| 02398265 | SILENOR | KNIGHT THERAPEUTICS INC. | Tablet | DOXEPIN (DOXEPIN HYDROCHLORIDE) 6 MG | Marketed |
| 00326925 | SINEQUAN | AA PHARMA INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 100 MG | Marketed |
| 00024325 | SINEQUAN | AA PHARMA INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 10 MG | Marketed |
| 00024333 | SINEQUAN | AA PHARMA INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 25 MG | Marketed |
| 00400750 | SINEQUAN | AA PHARMA INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 75 MG | Marketed |
| 00024341 | SINEQUAN | AA PHARMA INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 50 MG | Marketed |
| 02565102 | TARO-DOXEPIN | TARO PHARMACEUTICALS INC | Tablet | DOXEPIN (DOXEPIN HYDROCHLORIDE) 3 MG | Approved |
| 02565110 | TARO-DOXEPIN | TARO PHARMACEUTICALS INC | Tablet | DOXEPIN (DOXEPIN HYDROCHLORIDE) 6 MG | Approved |
| 02140071 | ALTI-DOXEPIN - CAP 10MG | ALTIMED PHARMA INC. | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 10 MG | Cancelled Post Market |
| 02140098 | ALTI-DOXEPIN-CAP 25MG | ALTIMED PHARMA INC. | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 25 MG | Cancelled Post Market |
| 02140101 | ALTI-DOXEPIN-CAP 50MG | ALTIMED PHARMA INC. | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 50 MG | Cancelled Post Market |
| 02140128 | ALTI-DOXEPIN-CAP 75MG | ALTIMED PHARMA INC. | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 75 MG | Cancelled Post Market |
| 02050056 | APO-DOXEPIN | APOTEX INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 150 MG | Dormant |
| 02150727 | DOXEPINE-10 - CAP | PRO DOC LIMITEE | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 10 MG | Cancelled Post Market |
| 02150778 | DOXEPINE-100 - CAP | PRO DOC LIMITEE | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 100 MG | Cancelled Post Market |
| 02150786 | DOXEPINE-150 - CAP | PRO DOC LIMITEE | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 150 MG | Cancelled Post Market |
| 02150735 | DOXEPINE-25 -CAP | PRO DOC LIMITEE | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 25 MG | Cancelled Post Market |
| 02150743 | DOXEPINE-50 - CAP | PRO DOC LIMITEE | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 50 MG | Cancelled Post Market |
| 02150751 | DOXEPINE-75 - CAP | PRO DOC LIMITEE | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 75 MG | Cancelled Post Market |
| 01913433 | NOVO-DOXEPIN | TEVA CANADA LIMITED | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 50 MG | Cancelled Post Market |
| 01913425 | NOVO-DOXEPIN | TEVA CANADA LIMITED | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 25 MG | Cancelled Post Market |
| 01913476 | NOVO-DOXEPIN | TEVA CANADA LIMITED | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 150 MG | Cancelled Post Market |
| 01913468 | NOVO-DOXEPIN | TEVA CANADA LIMITED | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 100 MG | Cancelled Post Market |
| 01913441 | NOVO-DOXEPIN | TEVA CANADA LIMITED | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 75 MG | Cancelled Post Market |
| 02144131 | RHO-DOXEPIN - CAP 25MG | RHODIAPHARM INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 25 MG | Cancelled Post Market |
| 02144158 | RHO-DOXEPIN - CAP 50MG | RHODIAPHARM INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 50 MG | Cancelled Post Market |
| 02144123 | RHO-DOXEPIN-10 MG CAP | RHODIAPHARM INC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 10 MG | Cancelled Post Market |
| 00584274 | SINEQUAN CAP 150MG | PFIZER CANADA ULC | Capsule | DOXEPIN (DOXEPIN HYDROCHLORIDE) 150 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35656 | 2025-07-10 | Abbreviated New Drug Submission (ANDS) |